$TSOI Companies are already taking advantage of the new law. For example, Therapeutic Solutions International recently announced that it will provide access to its clinical stage cancer immunotherapy product StemVacs.[3] It is hoped that the Right to Try law will benefit patients awaiting FDA approval on promising therapeutics.